Skip to main content
logo
Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.665
+0.145 (9.54%)
Nov 4, 2026, 5:25 PM CET

STO:NEWBRY Financials Overview

Millions SEK. Fiscal year is Sep - Aug.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Revenue
44.3944.3931.5736.8310.275.52
Revenue Growth
40.58%40.58%-14.27%258.75%86.11%78.73%
Gross Profit
12.312.312.8316.033.951.56
Operating Income
-20.66-20.66-20.61-14.47-18.12-13.99
Net Income
-22.93-22.93-23.88-15.41-19.43-14.67
Earnings Per Share
-0.75-0.75-0.92-0.72-1.00-0.82
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Net Cash (Debt)
9.349.3414.5615.38.5333.33
Net Cash Growth
-35.83%-35.83%-4.84%79.44%-74.42%153.59%
Net Cash Per Share
0.310.310.560.710.441.87
Cash & Investments
9.349.3414.5615.38.5333.33

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Operating Cash Flow
-19.68-19.68-12.37-23.71-23.23-15
Free Cash Flow
-19.68-19.68-12.37-23.71-23.23-15
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Gross Margin
27.71%27.71%40.63%43.53%38.46%28.35%
Operating Margin
-46.55%-46.55%-65.27%-39.29%-176.51%-253.57%
Pretax Margin
-51.64%-51.64%-74.76%-41.84%-189.28%-265.90%
Profit Margin
-51.65%-51.65%-75.65%-41.83%-189.28%-265.90%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Forward PE
-13.4513.45---
PS Ratio
1.081.722.492.177.6115.72